{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T07:59:59Z","timestamp":1775289599262,"version":"3.50.1"},"reference-count":89,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Continuum"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1212\/con.0000000000000414","type":"journal-article","created":{"date-parts":[[2016,12,6]],"date-time":"2016-12-06T09:31:58Z","timestamp":1481016718000},"page":"1889-1915","source":"Crossref","is-referenced-by-count":20,"title":["The Dystrophic and Nondystrophic Myotonias"],"prefix":"10.1212","volume":"22","author":[{"given":"Valeria A.","family":"Sansone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"12","key":"e_1_3_2_2_2","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.3748\/wjg.v12.i12.1821","article-title":"Gastrointestinal manifestations in myotonic muscular dystrophy","volume":"12","author":"Bellini M","year":"2006","unstructured":"Bellini M Biagi S Stasi C Gastrointestinal manifestations in myotonic muscular dystrophy. World J Gastroenterol 2006;12(12):1821\u20131828.","journal-title":"World J Gastroenterol"},{"issue":"8","key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.nmd.2008.06.366","article-title":"A putative role of ribonuclear inclusions and MBNL1 in the impairment of gallbladder smooth muscle contractility with cholelithiasis in myotonic dystrophy type 1","volume":"18","author":"Cardani R","year":"2008","unstructured":"Cardani R Mancinelli E Saino G A putative role of ribonuclear inclusions and MBNL1 in the impairment of gallbladder smooth muscle contractility with cholelithiasis in myotonic dystrophy type 1. Neuromuscul Disord 2008;18(8):641\u2013645. doi:10.1016\/j.nmd.2008.06.366.","journal-title":"Neuromuscul Disord"},{"issue":"4","key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1212\/01.WNL.0000054481.84978.F9","article-title":"Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum","volume":"60","author":"Day JW","year":"2003","unstructured":"Day JW Ricker K Jacobsen JF Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum. Neurology 2003;60(4):657\u2013664. doi:10.1212\/01.WNL.0000054481.84978.F9.","journal-title":"Neurology"},{"issue":"5531","key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1126\/science.1062125","article-title":"Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9","volume":"293","author":"Liquori CL","year":"2001","unstructured":"Liquori CL Ricker K Moseley ML Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 2001;293(5531):864\u2013867. doi:10.1126\/science.1062125.","journal-title":"Science"},{"issue":"4","key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1086\/378566","article-title":"Confirmation of the type 2 myotonic dystrophy (CCTG)n expansion mutation in patients with proximal myotonic myopathy\/proximal myotonic dystrophy of different European origins: a single shared haplotype indicates an ancestral founder effect","volume":"73","author":"Bachinski LL","year":"2003","unstructured":"Bachinski LL Udd B Meola G Confirmation of the type 2 myotonic dystrophy (CCTG)n expansion mutation in patients with proximal myotonic myopathy\/proximal myotonic dystrophy of different European origins: a single shared haplotype indicates an ancestral founder effect. Am J Hum Genet 2003;73(4):835\u2013848. doi:10.1086\/378566.","journal-title":"Am J Hum Genet"},{"issue":"3","key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s004390050225","article-title":"Recessive Schwartz-Jampel syndrome (SJS): confirmation of linkage to chromosome 1p, evidence of genetic homogeneity and reduction of the SJS locus to a 3-cM interval","volume":"98","author":"Fontaine B","year":"1996","unstructured":"Fontaine B Nicole S Topaloglu H Recessive Schwartz-Jampel syndrome (SJS): confirmation of linkage to chromosome 1p, evidence of genetic homogeneity and reduction of the SJS locus to a 3-cM interval. Hum Genet 1996;98(3):380\u2013385. doi:10.1007\/s004390050225.","journal-title":"Hum Genet"},{"issue":"2","key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1136\/jnnp.65.2.248","article-title":"Salbutamol treatment in a patient with hyperkalaemic periodic paralysis due to a mutation in the skeletal muscle sodium channel gene (SCN4A)","volume":"65","author":"Hanna MG","year":"1998","unstructured":"Hanna MG Stewart J Schapira AH Salbutamol treatment in a patient with hyperkalaemic periodic paralysis due to a mutation in the skeletal muscle sodium channel gene (SCN4A). J Neurol Neurosurg Psychiatry 1998;65(2):248\u2013250. doi:10.1136\/jnnp.65.2.248.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0960-8966(97)00046-1","article-title":"Channelopathies: ion channel disorders of muscle as a paradigm for paroxysmal disorders of the nervous system","volume":"7","author":"Pt\u00e1\u010dek LJ","year":"1997","unstructured":"Pt\u00e1\u010dek LJ. Channelopathies: ion channel disorders of muscle as a paradigm for paroxysmal disorders of the nervous system. Neuromuscul Disord 1997;7(4):250\u2013255. doi:10.1016\/S0960-8966(97)00046-1.","journal-title":"Neuromuscul Disord"},{"issue":"5","key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1086\/340390","article-title":"Structural and functional mutations of the perlecan gene cause Schwartz-Jampel syndrome, with myotonic myopathy and chondrodysplasia","volume":"70","author":"Arikawa-Hirasawa E","year":"2002","unstructured":"Arikawa-Hirasawa E Le AH Nishino I Structural and functional mutations of the perlecan gene cause Schwartz-Jampel syndrome, with myotonic myopathy and chondrodysplasia. Am J Hum Genet 2002;70(5):1368\u20131375. doi:10.1086\/340390.","journal-title":"Am J Hum Genet"},{"issue":"11","key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/humu.20388","article-title":"Spectrum of HSPG2 (Perlecan) mutations in patients with Schwartz-Jampel syndrome","volume":"27","author":"Stum M","year":"2006","unstructured":"Stum M Davoine CS Vicart S Spectrum of HSPG2 (Perlecan) mutations in patients with Schwartz-Jampel syndrome. Hum Mutat 2006;27(11):1082\u20131091. doi:10.1002\/humu.20388.","journal-title":"Hum Mutat"},{"issue":"5","key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/ana.20241","article-title":"Electromyography guides toward subgroups of mutations in muscle channelopathies","volume":"56","author":"Fournier E","year":"2004","unstructured":"Fournier E Arzel M Sternberg D Electromyography guides toward subgroups of mutations in muscle channelopathies. Ann Neurol 2004;56(5):650\u2013661. doi:10.1002\/ana.20241.","journal-title":"Ann Neurol"},{"issue":"2","key":"e_1_3_2_13_2","first-page":"385","article-title":"Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3\u2019 end of a transcript encoding a protein kinase family member","volume":"69","author":"Brook JD","year":"1992","unstructured":"Brook JD McCurrach ME Harley HG Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3\u2019 end of a transcript encoding a protein kinase family member. Cell 1992;69(2):385. doi:10.1016\/0092-8674(92)90154-5.","journal-title":"Cell"},{"issue":"5049","key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1126\/science.1546326","article-title":"An unstable triplet repeat in a gene related to myotonic muscular dystrophy","volume":"255","author":"Fu YH","year":"1992","unstructured":"Fu YH Pizzuti A Fenwick RGJr An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 1992;255(5049):1256\u20131258. doi:10.1126\/science.1546326.","journal-title":"Science"},{"issue":"5049","key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1126\/science.1546325","article-title":"Myotonic dystrophy mutation: an unstable CTG repeat in the 3\u2019 untranslated region of the gene","volume":"255","author":"Mahadevan M","year":"1992","unstructured":"Mahadevan M Tsilfidis C Sabourin L Myotonic dystrophy mutation: an unstable CTG repeat in the 3\u2019 untranslated region of the gene. Science 1992;255(5049):1253\u20131255. doi:10.1126\/science.1546325.","journal-title":"Science"},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"958510","DOI":"10.1155\/2013\/958510","article-title":"Identification and characterization of DM1 patients by a new diagnostic certified assay: neuromuscular and cardiac assessments","volume":"2013","author":"Valaperta R","year":"2013","unstructured":"Valaperta R Sansone V Lombardi F Identification and characterization of DM1 patients by a new diagnostic certified assay: neuromuscular and cardiac assessments. Biomed Res Int 2013;2013:958510. doi:10.1155\/2013\/958510.","journal-title":"Biomed Res Int"},{"issue":"3","key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.nmd.2013.11.001","article-title":"Most expression and splicing changes in myotonic dystrophy type 1 and type 2 skeletal muscle are shared with other muscular dystrophies","volume":"24","author":"Bachinski LL","year":"2014","unstructured":"Bachinski LL Baggerly KA Neubauer VL Most expression and splicing changes in myotonic dystrophy type 1 and type 2 skeletal muscle are shared with other muscular dystrophies. Neuromuscul Disord 2014;24(3):227\u2013240. doi:10.1016\/j.nmd.2013.11.001.","journal-title":"Neuromuscul Disord"},{"issue":"19","key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1093\/hmg\/10.19.2165","article-title":"Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2","volume":"10","author":"Mankodi A","year":"2001","unstructured":"Mankodi A Urbinati CR Yuan QP Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2. Hum Mol Genet 2001;10(19):2165\u201321670. doi:10.1093\/hmg\/10.19.2165.","journal-title":"Hum Mol Genet"},{"issue":"17","key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"4439","DOI":"10.1093\/emboj\/19.17.4439","article-title":"Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy","volume":"19","author":"Miller JW","year":"2000","unstructured":"Miller JW Urbinati CR Teng-Umnuay P Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy. EMBO J 2000;19(17):4439\u20134448. doi:10.1093\/emboj\/19.17.4439.","journal-title":"EMBO J"},{"issue":"5364","key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1126\/science.280.5364.737","article-title":"Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy","volume":"280","author":"Philips AV","year":"1998","unstructured":"Philips AV Timchenko LT Cooper TA. Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science 1998;280(5364):737\u2013741. doi:10.1126\/science.280.5364.737.","journal-title":"Science"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.385"},{"issue":"9","key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1212\/01.wnl.0000302174.08951.cf","article-title":"Aberrantly spliced alpha-dystrobrevin alters alpha-syntrophin binding in myotonic dystrophy type 1","volume":"70","author":"Nakamori M","year":"2008","unstructured":"Nakamori M Kimura T Kubota T Aberrantly spliced alpha-dystrobrevin alters alpha-syntrophin binding in myotonic dystrophy type 1. Neurology 2008;70(9):677\u2013685. doi:10.1212\/01.wnl.0000302174.08951.cf.","journal-title":"Neurology"},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"7205","DOI":"10.1038\/ncomms8205","article-title":"Abnormal splicing switch of DMD\u2019s penultimate exon compromises muscle fibre maintenance in myotonic dystrophy","volume":"6","author":"Rau F","year":"2015","unstructured":"Rau F Lain\u00e9 J Ramanoudjame L Abnormal splicing switch of DMD\u2019s penultimate exon compromises muscle fibre maintenance in myotonic dystrophy. Nat Commun 2015;6:7205. doi:10.1038\/ncomms8205.","journal-title":"Nat Commun"},{"issue":"4","key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"C1291","DOI":"10.1152\/ajpcell.00336.2006","article-title":"Chloride channelopathy in myotonic dystrophy resulting from loss of posttranscriptional regulation for CLCN1","volume":"292","author":"Lueck JD","year":"2007","unstructured":"Lueck JD Lungu C Mankodi A Chloride channelopathy in myotonic dystrophy resulting from loss of posttranscriptional regulation for CLCN1. Am J Physiol Cell Physiol 2007;292(4):C1291\u2013C1297. doi:10.1152\/ajpcell.00336.2006.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"12","key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1261\/rna.610607","article-title":"MBNL binds similar RNA structures in the CUG repeats of myotonic dystrophy and its pre-mRNA substrate cardiac troponin T","volume":"13","author":"Warf MB","year":"2007","unstructured":"Warf MB Berglund JA. MBNL binds similar RNA structures in the CUG repeats of myotonic dystrophy and its pre-mRNA substrate cardiac troponin T. RNA 2007;13(12):2238\u20132251. doi:10.1261\/rna.610607.","journal-title":"RNA"},{"issue":"1","key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/ng704","article-title":"Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance inmyotonic dystrophy","volume":"29","author":"Savkur RS","year":"2001","unstructured":"Savkur RS Philips AV Cooper TA. Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance inmyotonic dystrophy. Nat Genet 2001;29(1):40\u201347. doi:10.1038\/ng704.","journal-title":"Nat Genet"},{"issue":"3","key":"e_1_3_2_27_2","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/hmg\/8.3.481","article-title":"Characterization of the expression of DMPK and SIX5 in the human eye and implications for pathogenesis in myotonic dystrophy","volume":"8","author":"Winchester CL","year":"1999","unstructured":"Winchester CL Ferrier RK Sermoni A Characterization of the expression of DMPK and SIX5 in the human eye and implications for pathogenesis in myotonic dystrophy. Hum Mol Genet 1999;8(3):481\u2013492.","journal-title":"Hum Mol Genet"},{"issue":"24","key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1093\/hmg\/ddl432","article-title":"Increased SK3 expression in DM1 lens cells leads to impaired growth through a greater calcium-induced fragility","volume":"15","author":"Rhodes JD","year":"2006","unstructured":"Rhodes JD Monckton DG McAbney JP Increased SK3 expression in DM1 lens cells leads to impaired growth through a greater calcium-induced fragility. Hum Mol Genet 2006;15(24):3559\u20133568. doi:10.1093\/hm1\/ddl432.","journal-title":"Hum Mol Genet"},{"key":"e_1_3_2_29_2","first-page":"57","article-title":"Brain pathology in myotonic dystrophy: when tauopathy meets spliceopathy and RNAopathy","volume":"6","author":"Caillet-Boudin ML","year":"2014","unstructured":"Caillet-Boudin ML Fernandez-Gomez FJ Tran H Brain pathology in myotonic dystrophy: when tauopathy meets spliceopathy and RNAopathy. Front Mol Neurosci 2014;6:57. doi:10.3389\/fnmol.2013.00057.","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"e_1_3_2_30_2","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jpeds.2012.12.070","article-title":"Congenital myotonic dystrophy: Canadian population-based surveillance study","volume":"163","author":"Campbell C","year":"2013","unstructured":"Campbell C Levin S Siu VM Congenital myotonic dystrophy: Canadian population-based surveillance study. J Pediatr 2013;163(1):120\u2013125. doi:10.1016\/j.jpeds.2012.12.070.","journal-title":"J Pediatr"},{"issue":"2","key":"e_1_3_2_31_2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/adc.68.2.177","article-title":"The natural history of congenital myotonic dystrophy: mortality and long term clinical aspects","volume":"68","author":"Reardon W","year":"1993","unstructured":"Reardon W Newcombe R Fenton I The natural history of congenital myotonic dystrophy: mortality and long term clinical aspects. Arch Dis Child 1993;68(2):177\u2013181. doi:10.1136\/adc.68.2.177.","journal-title":"Arch Dis Child"},{"key":"e_1_3_2_32_2","article-title":"Parent-reported multi-national study of the impact of congenital and childhood onset myotonic dystrophy","author":"Johnson NE","year":"2015","unstructured":"Johnson NE Ekstrom AB Campbell C Parent-reported multi-national study of the impact of congenital and childhood onset myotonic dystrophy. Dev Med Child Neurol 2015. doi:10.1111\/dmcn.12948.","journal-title":"Dev Med Child Neurol"},{"issue":"9","key":"e_1_3_2_33_2","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.nmd.2006.06.007","article-title":"Sleep disorders in childhood-onset myotonic dystrophy type 1","volume":"16","author":"Quera Salva MA","year":"2006","unstructured":"Quera Salva MA Blumen M Jacquette A Sleep disorders in childhood-onset myotonic dystrophy type 1. Neuromuscul Disord 2006;16(9-10):564\u2013570. doi:10.1016\/j.nmd.2006.06.007.","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"e_1_3_2_34_2","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/S0828-282X(09)70479-9","article-title":"Usefulness of clinical and electrocardiographic data for predicting adverse cardiac events in patients with myotonic dystrophy","volume":"25","author":"Breton R","year":"2009","unstructured":"Breton R Mathieu J. Usefulness of clinical and electrocardiographic data for predicting adverse cardiac events in patients with myotonic dystrophy. Can J Cardiol 2009;25(2):e23\u2013e27. doi:10.1016\/S0828-282X(09)70479-9.34.","journal-title":"Can J Cardiol"},{"issue":"25","key":"e_1_3_2_35_2","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1056\/NEJMoa062800","article-title":"Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1","volume":"358","author":"Groh WJ","year":"2008","unstructured":"Groh WJ Groh MR Saha C Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1. N Engl J Med 2008;358(25):2688\u20132697. doi:10.1056\/NEJMoa062800.","journal-title":"N Engl J Med"},{"issue":"5","key":"e_1_3_2_36_2","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/mus.20156","article-title":"Cardiac and skeletal muscle involvement in myotonic dystrophy type 2 (DM2): a quantitative 31P-MRS and MRI study","volume":"30","author":"Schneider-Gold C","year":"2004","unstructured":"Schneider-Gold C Beer M K\u00f6stler H Cardiac and skeletal muscle involvement in myotonic dystrophy type 2 (DM2): a quantitative 31P-MRS and MRI study. Muscle Nerve 2004;30(5):636\u2013644. doi:10.1002\/mus.20156.","journal-title":"Muscle Nerve"},{"issue":"3","key":"e_1_3_2_37_2","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1212\/01.wnl.0000296827.20167.98","article-title":"The hypocretin neurotransmission system in myotonic dystrophy type 1","volume":"70","author":"Ciafaloni E","year":"2008","unstructured":"Ciafaloni E Mignot E Sansone V The hypocretin neurotransmission system in myotonic dystrophy type 1. Neurology 2008;70(3):226\u2013230. doi:10.1212\/01.wnl.0000296827.20167.98.","journal-title":"Neurology"},{"issue":"6","key":"e_1_3_2_38_2","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/S0016-5085(84)80160-2","article-title":"Functional abnormalities of the anal sphincters in patients with myotonic dystrophy","volume":"86","author":"Hamel-Roy J","year":"1984","unstructured":"Hamel-Roy J Devroede G Arhan P Functional abnormalities of the anal sphincters in patients with myotonic dystrophy. Gastroenterology 1984;86(6):1469\u20131474.","journal-title":"Gastroenterology"},{"issue":"6","key":"e_1_3_2_39_2","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/mus.24097","article-title":"Myotonic Dystrophy Health Index: initial evaluation of a disease-specific outcome measure","volume":"49","author":"Heatwole C","year":"2014","unstructured":"Heatwole C Bode R Johnson N Myotonic Dystrophy Health Index: initial evaluation of a disease-specific outcome measure. Muscle Nerve 2014;49(6):906\u2013914. doi:10.1002\/mus.24097.","journal-title":"Muscle Nerve"},{"issue":"5","key":"e_1_3_2_40_2","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/BF01999897","article-title":"A newly-described myotonic disorder (proximal myotonic myopathy\u2014PROMM): personal experience and review of the literature","volume":"17","author":"Meola G","year":"1996","unstructured":"Meola G Sansone V. A newly-described myotonic disorder (proximal myotonic myopathy\u2014PROMM): personal experience and review of the literature. Ital J Neurol Sci 1996;17(5):347\u2013353. doi:10.1007\/BF01999897.","journal-title":"Ital J Neurol Sci"},{"issue":"6","key":"e_1_3_2_41_2","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.nmd.2012.01.003","article-title":"Cerebral and muscle MRI abnormalities in myotonic dystrophy","volume":"22","author":"Franc DT","year":"2012","unstructured":"Franc DT Muetzel RL Robinson PR Cerebral and muscle MRI abnormalities in myotonic dystrophy. Neuromuscul Disord 2012;22(6):483\u2013491. doi:10.1016\/j.nmd.2012.01.003.","journal-title":"Neuromuscul Disord"},{"issue":"7","key":"e_1_3_2_42_2","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/eci.12459","article-title":"Gonadal failure is associated with visceral adiposity in myotonic dystrophies","volume":"45","author":"Passeri E","year":"2015","unstructured":"Passeri E Bugiardini E Sansone VA Gonadal failure is associated with visceral adiposity in myotonic dystrophies. Eur J Clin Invest 2015;45(7):702\u2013710. doi:10.1111\/eci.12459.","journal-title":"Eur J Clin Invest"},{"issue":"5","key":"e_1_3_2_43_2","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1086\/383590","article-title":"Myotonic dystrophy: RNA pathogenesis comes into focus","volume":"74","author":"Ranum LP","year":"2004","unstructured":"Ranum LP Day JW. Myotonic dystrophy: RNA pathogenesis comes into focus. Am J Hum Genet 2004;74(5):793\u2013804. doi:10.1086\/383590.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"e_1_3_2_44_2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0960-8966(97)00041-2","article-title":"Proximal myotonic dystrophy\u2014a family with autosomal dominant muscular dystrophy, cataracts, hearing loss and hypogonadism: heterogeneity of proximal myotonic syndromes?","volume":"7","author":"Udd B","year":"1997","unstructured":"Udd B Krahe R Wallgren-Pettersson C Proximal myotonic dystrophy\u2014a family with autosomal dominant muscular dystrophy, cataracts, hearing loss and hypogonadism: heterogeneity of proximal myotonic syndromes? Neuromuscul Disord 1997;7(4):217\u2013228. doi:10.1016\/S0960-8966(97)00041-2.","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"e_1_3_2_45_2","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1468-1331.2004.01032.x","article-title":"Proximal myotonic dystrophy mimicking progressive muscular atrophy","volume":"12","author":"Rotondo G","year":"2005","unstructured":"Rotondo G Sansone V Cardani R Proximal myotonic dystrophy mimicking progressive muscular atrophy. Eur J Neurol 2005;12(2):160\u2013161. doi:10.1111\/j.1468-1331.2004.01032.x.","journal-title":"Eur J Neurol"},{"issue":"6","key":"e_1_3_2_46_2","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/mus.20289","article-title":"Hyper-CK-emia as the sole manifestation of myotonic dystrophy type 2","volume":"31","author":"Merlini L","year":"2005","unstructured":"Merlini L Sabatelli P Columbaro M Hyper-CK-emia as the sole manifestation of myotonic dystrophy type 2. Muscle Nerve 2005;31(6):764\u2013767. doi:10.1002\/mus.20289.","journal-title":"Muscle Nerve"},{"issue":"11","key":"e_1_3_2_47_2","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1212\/01.WNL.0000145765.19094.94","article-title":"Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkin disease","volume":"63","author":"Varrone A","year":"2004","unstructured":"Varrone A Pellecchia MT Amboni M Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkin disease. Neurology 2004;63(11):2097\u20132103. doi:10.1212\/01.WNL.0000145765.19094.94.","journal-title":"Neurology"},{"issue":"1","key":"e_1_3_2_48_2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/archneur.1995.00540250029009","article-title":"Proximal myotonic myopathy. Clinical features of a multisystem disorder similar to myotonic dystrophy","volume":"52","author":"Ricker K","year":"1995","unstructured":"Ricker K Koch MC Lehmann-Horn F Proximal myotonic myopathy. Clinical features of a multisystem disorder similar to myotonic dystrophy. Arch Neurol 1995;52(1):25\u201331.","journal-title":"Arch Neurol"},{"issue":"2","key":"e_1_3_2_49_2","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.ijcard.2012.11.076","article-title":"The frequency and severity of cardiac involvement in myotonic dystrophy type 2 (DM2): long-term outcomes","volume":"168","author":"Sansone VA","year":"2013","unstructured":"Sansone VA Brigonzi E Schoser B The frequency and severity of cardiac involvement in myotonic dystrophy type 2 (DM2): long-term outcomes. Int J Cardiol 2013;168(2):1147\u20131153. doi:10.1016\/j.ijcard.2012.11.076.","journal-title":"Int J Cardiol"},{"issue":"12","key":"e_1_3_2_50_2","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1212\/01.WNL.0000147335.10783.E4","article-title":"Sudden cardiac death in myotonic dystrophy type 2","volume":"63","author":"Schoser BG","year":"2004","unstructured":"Schoser BG Ricker K Schneider-Gold C Sudden cardiac death in myotonic dystrophy type 2. Neurology 2004;63(12):2402\u20132404.","journal-title":"Neurology"},{"issue":"5","key":"e_1_3_2_51_2","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.nmd.2015.01.011","article-title":"207th ENMC Workshop on chronic respiratory insufficiency in myotonic dystrophies: management and implications for research, 27-29 June 2014, Naarden, The Netherlands","volume":"25","author":"Sansone VA","year":"2015","unstructured":"Sansone VA Gagnon C; Participants of the 207th ENMC Workshop. 207th ENMC Workshop on chronic respiratory insufficiency in myotonic dystrophies: management and implications for research, 27-29 June 2014, Naarden, The Netherlands. Neuromuscul Disord 2015;25(5):432\u2013442. doi:10.1016\/j.nmd.2015.01.011.","journal-title":"Neuromuscul Disord"},{"issue":"5","key":"e_1_3_2_52_2","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1212\/WNL.53.5.1042","article-title":"Reduced cerebral blood flow and impaired visual-spatial function in proximal myotonic myopathy","volume":"53","author":"Meola G","year":"1999","unstructured":"Meola G Sansone V Perani D Reduced cerebral blood flow and impaired visual-spatial function in proximal myotonic myopathy. Neurology 1999;53(5):1042\u20131050.","journal-title":"Neurology"},{"issue":"10","key":"e_1_3_2_53_2","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0960-8966(03)00137-8","article-title":"Executive dysfunction and avoidant personality trait in myotonic dystrophy type 1 (DM-1) and in proximal myotonic myopathy (PROMM\/DM-2)","volume":"13","author":"Meola G","year":"2003","unstructured":"Meola G Sansone V Perani D Executive dysfunction and avoidant personality trait in myotonic dystrophy type 1 (DM-1) and in proximal myotonic myopathy (PROMM\/DM-2). Neuromuscul Disord 2003;13(10):813\u2013821.","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"e_1_3_2_54_2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1136\/jnnp.2005.078451","article-title":"Glucose metabolism and dopamine PET correlates in a patient with myotonic dystrophy type 2 and parkinsonism","volume":"77","author":"Sansone V","year":"2006","unstructured":"Sansone V Meola G Perani D Glucose metabolism and dopamine PET correlates in a patient with myotonic dystrophy type 2 and parkinsonism. J Neurol Neurosurg Psychiatry 2006;77(3):425\u2013426. doi:10.1136\/jnnp.2005.078451.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"e_1_3_2_55_2","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/mus.20800","article-title":"Cerebral involvement in myotonic dystrophies","volume":"36","author":"Meola G","year":"2007","unstructured":"Meola G Sansone V. Cerebral involvement in myotonic dystrophies. Muscle Nerve 2007;36(3):294\u2013306. doi:10.1002\/mus.20800.","journal-title":"Muscle Nerve"},{"issue":"6","key":"e_1_3_2_56_2","doi-asserted-by":"crossref","first-page":"e0130352","DOI":"10.1371\/journal.pone.0130352","article-title":"Cortical and subcortical grey and white matter atrophy in myotonic dystrophies type 1 and 2 is associated with cognitive impairment, depression and daytime sleepiness","volume":"10","author":"Schneider-Gold C","unstructured":"Schneider-Gold C Bellenberg B Prehn C Cortical and subcortical grey and white matter atrophy in myotonic dystrophies type 1 and 2 is associated with cognitive impairment, depression and daytime sleepiness. PLoS One 201;10(6):e0130352. doi:10.1371\/journal.pone.0130352.","journal-title":"PLoS One"},{"issue":"12","key":"e_1_3_2_57_2","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1093\/brain\/awr299","article-title":"The brain in myotonic dystrophy 1 and 2: evidence for a predominant white matter disease","volume":"134","author":"Minnerop M","year":"2011","unstructured":"Minnerop M Weber B Schoene-Bake JC The brain in myotonic dystrophy 1 and 2: evidence for a predominant white matter disease. Brain 2011;134(12):3530\u20133546. doi:10.1093\/brain\/awr299","journal-title":"Brain"},{"issue":"3","key":"e_1_3_2_58_2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0960-8966(99)00097-8","article-title":"Hypothyroidism unmasking proximal myotonic myopathy","volume":"10","author":"Sansone V","year":"2000","unstructured":"Sansone V Griggs RC Moxley RT3rd. Hypothyroidism unmasking proximal myotonic myopathy. Neuromuscul Disord 2000;10(3):165\u2013172. doi:10.1016\/S0960-8966(99)00097-8.","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"e_1_3_2_59_2","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0960-8966(98)00118-7","article-title":"Proximal myotonic myopathy (PROMM) presenting as myotonia during pregnancy","volume":"9","author":"Newman B","year":"1999","unstructured":"Newman B Meola G O\u2019Donovan D Proximal myotonic myopathy (PROMM) presenting as myotonia during pregnancy. Neuromuscul Disord 1999;9(3):144\u2013149. doi:10.1016\/S0960-8966(98)00118-7.","journal-title":"Neuromuscul Disord"},{"issue":"11","key":"e_1_3_2_60_2","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1212\/WNL.55.11.1697","article-title":"A \u201cdystrophic\u201d variant of autosomal recessive myotonia congenita caused by novel mutations in the CLCN1 gene","volume":"55","author":"Nagamitsu S","year":"2000","unstructured":"Nagamitsu S Matsuura T Khajavi M A \u201cdystrophic\u201d variant of autosomal recessive myotonia congenita caused by novel mutations in the CLCN1 gene. Neurology 2000;55(11):1697\u20131703. doi:10.1212\/WNL.55.11.1697.","journal-title":"Neurology"},{"issue":"4","key":"e_1_3_2_61_2","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1136\/jnnp.64.4.543","article-title":"Dominantly inherited proximal myotonic myopathy and leukoencephalopathy in a family with an incidental CLCN1 mutation","volume":"64","author":"Mastaglia FL","year":"1998","unstructured":"Mastaglia FL Harker N Phillips BA Dominantly inherited proximal myotonic myopathy and leukoencephalopathy in a family with an incidental CLCN1 mutation. J Neurol Neurosurg Psychiatry 1998;64(4):543\u2013547. doi:10.1136\/jnnp.64.4.543.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"e_1_3_2_62_2","unstructured":"Clinicaltrials.gov website. Children\u2019s Health Research Institute (CHRI) Stanford Lucile Packard Children Hospital (LPCH) Protocol on Myotonic Dystrophy (CHRI) (NCT02269865). clinicaltrials.gov\/ct2\/show\/NCT02269865?term=NCT02269865&rank=1. Updated October 16 2014. Accessed October 17 2016."},{"key":"e_1_3_2_63_2","unstructured":"Clinicaltrials.gov website. Multicenter Observational Study of Myotonic Dystrophy Type 1 (MOS-DM1) (NCT02308657). clinicaltrials.gov\/ct2\/show\/NCT02308657?term=NCT02308657&rank=1 Updated September 15 2016. Accessed October 17 2016."},{"key":"e_1_3_2_64_2","unstructured":"Clinicaltrials.gov website. Observational Prolonged Trial in Myotonic Dystrophy Type 1 (OPTIMISTIC) (NCT02118779). clinicaltrials.gov\/ct2\/show\/NCT02118779?term=NCT02118779&rank=1. Updated July 28 2015. Accessed October 17 2016."},{"key":"e_1_3_2_65_2","unstructured":"Clinicaltrials.gov website. A Safety and Tolerability Study of Multiple Doses of ISIS-DMPKRx in Adults With Myotonic Dystrophy Type 1 (NCT02312011). clinicaltrials.gov\/ct2\/show\/NCT02312011?term=NCT02312011&rank=1. Updated September 1 2016. Accessed October 17 2016."},{"key":"e_1_3_2_66_2","unstructured":"Clinicaltrials.gov website. Clinical Efficacy Trial of Mexiletine for Myotonic Dystrophy Type 1 (NCT01406873). clinicaltrials.gov\/ct2\/show\/NCT01406873?term=NCT01406873&rank=1. Updated September 1 2016. Accessed October 17 2016."},{"issue":"5","key":"e_1_3_2_67_2","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1093\/bja\/65.5.692","article-title":"Are myotonias and periodic paralyses associated with susceptibility to malignant hyperthermia?","volume":"65","author":"Lehmann-Horn F","year":"1990","unstructured":"Lehmann-Horn F Iaizzo PA. Are myotonias and periodic paralyses associated with susceptibility to malignant hyperthermia? Br J Anaesth 1990;65(5):692\u2013697. doi:10.1093\/bja\/65.5.692.","journal-title":"Br J Anaesth"},{"issue":"4","key":"e_1_3_2_68_2","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1212\/WNL.0b013e318260cbe6","article-title":"Patient-reported impact of symptoms in myotonic dystrophy type 1 (PRISM-1)","volume":"79","author":"Heatwole C","year":"2012","unstructured":"Heatwole C Bode R Johnson N Patient-reported impact of symptoms in myotonic dystrophy type 1 (PRISM-1). Neurology 2012;79(4):348\u2013357. doi:10.1212\/WNL.0b013e318260cbe6.","journal-title":"Neurology"},{"issue":"3","key":"e_1_3_2_69_2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/16501970500477967","article-title":"Health-related quality of life in myotonic dystrophy type 1 and its relationship with cognitive and emotional functioning","volume":"38","author":"Antonini G","year":"2006","unstructured":"Antonini G Soscia F Giubilei F Health-related quality of life in myotonic dystrophy type 1 and its relationship with cognitive and emotional functioning. J Rehabil Med 2006;38(3):181\u2013185. doi:10.1080\/16501970500477967.","journal-title":"J Rehabil Med"},{"issue":"9","key":"e_1_3_2_70_2","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1111\/j.1468-1331.2010.02992.x","article-title":"Italian validation of INQoL, a quality of life questionnaire for adults with muscle diseases","volume":"17","author":"Sansone VA","year":"2010","unstructured":"Sansone VA Panzeri M Montanari M Italian validation of INQoL, a quality of life questionnaire for adults with muscle diseases. Eur J Neurol 2010;17(9):1178\u20131187. doi:10.1111\/j.1468-1331.2010.02992.x.","journal-title":"Eur J Neurol"},{"issue":"1","key":"e_1_3_2_71_2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0166-2236(96)81859-5","article-title":"Ion-channel defects and aberrant excitability in myotonia and periodic paralysis","volume":"19","author":"Cannon SC","year":"1996","unstructured":"Cannon SC. Ion-channel defects and aberrant excitability in myotonia and periodic paralysis. Trends Neurosci 1996;19(1):3\u201310. doi:10.1016\/0166-2236(96)81859-5.","journal-title":"Trends Neurosci"},{"issue":"4","key":"e_1_3_2_72_2","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1136\/jnnp.2008.164046","article-title":"Diagnosis and new treatment in muscle channelopathies","volume":"80","author":"Meola G","year":"2009","unstructured":"Meola G Hanna MG Fontaine B. Diagnosis and new treatment in muscle channelopathies. J Neurol Neurosurg Psychiatry 2009;80(4):360\u2013365. doi:10.1136\/jnnp.2008.164046.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"e_1_3_2_73_2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/ana.410420306","article-title":"Andersen\u2019s syndrome: a distinct periodic paralysis","volume":"42","author":"Sansone V","year":"1997","unstructured":"Sansone V Griggs RC Meola G Andersen\u2019s syndrome: a distinct periodic paralysis. Ann Neurol 1997;42(3):305\u2013312. doi:10.1002\/ana.410420306.","journal-title":"Ann Neurol"},{"issue":"3","key":"e_1_3_2_74_2","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1172\/JCI15183","article-title":"Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome)","volume":"110","author":"Tristani-Firouzi M","year":"2002","unstructured":"Tristani-Firouzi M Jensen JL Donaldson MR Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome). J Clin Invest 2002;110(3):381\u2013388.","journal-title":"J Clin Invest"},{"issue":"11","key":"e_1_3_2_75_2","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1111\/j.1468-1331.2012.03751.x","article-title":"Measuring quality of life impairment in skeletal muscle channelopathies","volume":"19","author":"Sansone VA","year":"2012","unstructured":"Sansone VA Ricci C Montanari M Measuring quality of life impairment in skeletal muscle channelopathies. Eur J Neurol 2012;19(11):1470\u20131476. doi:10.1111\/j.1468-1331.2012.03751.x.","journal-title":"Eur J Neurol"},{"issue":"11","key":"e_1_3_2_76_2","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1113\/jphysiol.2009.186627","article-title":"Muscle channelopathies: does the predicted channel gating pore offer new treatment insights for hypokalaemic periodic paralysis?","volume":"588","author":"Matthews E","year":"2010","unstructured":"Matthews E Hanna MG. Muscle channelopathies: does the predicted channel gating pore offer new treatment insights for hypokalaemic periodic paralysis? J Physiol 2010;588(pt 11):1879\u20131886. doi:10.1113\/jphysiol.2009.186627.","journal-title":"J Physiol"},{"issue":"5071","key":"e_1_3_2_77_2","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1126\/science.1379744","article-title":"The skeletal muscle chloride channel in dominant and recessive human myotonia","volume":"257","author":"Koch MC","year":"1992","unstructured":"Koch MC Steinmeyer K Lorenz C The skeletal muscle chloride channel in dominant and recessive human myotonia. Science 1992;257(5071):797\u2013800. doi:10.1126\/science.1379744.","journal-title":"Science"},{"issue":"6","key":"e_1_3_2_78_2","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1073\/pnas.94.6.2729","article-title":"A mutation in autosomal dominant myotonia congenita affects pore properties of the muscle chloride channel","volume":"94","author":"Fahlke C","year":"1997","unstructured":"Fahlke C Beck CL George ALJr. A mutation in autosomal dominant myotonia congenita affects pore properties of the muscle chloride channel. Proc Natl Acad Sci U S A 1997;94(6):2729\u20132734.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"e_1_3_2_79_2","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1093\/brain\/awm248","article-title":"Chloride channel myotonia: exon 8 hot-spot for dominant-negative interactions","volume":"130","author":"Fialho D","year":"2007","unstructured":"Fialho D Schorge S Pucovska U Chloride channel myotonia: exon 8 hot-spot for dominant-negative interactions. Brain 2007;130(pt 12):3265\u20133274.","journal-title":"Brain"},{"issue":"3","key":"e_1_3_2_80_2","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1007\/BF02164912","article-title":"Tonische Kr\u00e4mpfe in willk\u00fcrlich beweglichen Muskeln in Folge von ererbter psychischer Disposition","volume":"6","author":"Thomsen J","year":"1876","unstructured":"Thomsen J. Tonische Kr\u00e4mpfe in willk\u00fcrlich beweglichen Muskeln in Folge von ererbter psychischer Disposition. Arch Psychiatr Nervenkr 1876;6(3):702\u2013718. doi:10.1007\/BF02164912.","journal-title":"Arch Psychiatr Nervenkr"},{"issue":"2","key":"e_1_3_2_81_2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/mus.880020205","article-title":"The autosomal recessive (Becker) form of myotonia congenita","volume":"2","author":"Kuhn E","year":"1979","unstructured":"Kuhn E Fiehn W Seiler D Schr\u00f6der JM. The autosomal recessive (Becker) form of myotonia congenita. Muscle Nerve 1979;2(2):109\u2013117.","journal-title":"Muscle Nerve"},{"issue":"2","key":"e_1_3_2_82_2","first-page":"317","article-title":"Novel muscle chloride channel mutations and their effects on heterozygous carriers","volume":"58","author":"Mail\u00e4nder V","year":"1996","unstructured":"Mail\u00e4nder V Heine R Deymeer F Lehmann-Horn F. Novel muscle chloride channel mutations and their effects on heterozygous carriers. Am J Hum Genet 1996;58(2):317\u2013324.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"e_1_3_2_83_2","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0960-8966(02)00272-9","article-title":"102nd ENMC International Workshop on Schwartz-Jampel syndrome, 14-16 December, 2001, Naarden, The Netherlands","volume":"13","author":"Nicole S","year":"2003","unstructured":"Nicole S Topaloglu H Fontaine B. 102nd ENMC International Workshop on Schwartz-Jampel syndrome, 14-16 December, 2001, Naarden, The Netherlands. Neuromuscul Disord 2003;13(4):347\u2013351. doi:10.1016\/S0960-8966(02)00272-9.","journal-title":"Neuromuscul Disord"},{"issue":"4","key":"e_1_3_2_84_2","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1083\/jcb.145.4.911","article-title":"Acetylcholinesterase clustering at the neuromuscular junction involves perlecan and dystroglycan","volume":"145","author":"Peng HB","year":"1999","unstructured":"Peng HB Xie H Rossi SG Rotundo RL. Acetylcholinesterase clustering at the neuromuscular junction involves perlecan and dystroglycan. J Cell Biol 1999;145(4):911\u2013921. doi:10.1083\/jcb.145.4.91.","journal-title":"J Cell Biol"},{"issue":"20","key":"e_1_3_2_85_2","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1093\/hmg\/ddn213","article-title":"Evidence of a dosage effect and a physiological endplate acetylcholinesterase deficiency in the first mouse models mimicking Schwartz-Jampel syndrome neuromyotonia","volume":"17","author":"Stum M","year":"2008","unstructured":"Stum M Girard E Bangratz M Evidence of a dosage effect and a physiological endplate acetylcholinesterase deficiency in the first mouse models mimicking Schwartz-Jampel syndrome neuromyotonia. Hum Mol Genet 2008;17(20):3166\u20133179. doi:10.1093\/hmg\/ddn213.","journal-title":"Hum Mol Genet"},{"issue":"4","key":"e_1_3_2_86_2","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/mus.20722","article-title":"Severity, type, and distribution of myotonic discharges are different in type 1 and type 2 myotonic dystrophy","volume":"35","author":"Logigian EL","year":"2007","unstructured":"Logigian EL Ciafaloni E Quinn LC Severity, type, and distribution of myotonic discharges are different in type 1 and type 2 myotonic dystrophy. Muscle Nerve 2007;35(4):479\u2013485. doi:10.1002\/mus.20722.","journal-title":"Muscle Nerve"},{"issue":"6","key":"e_1_3_2_87_2","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1212\/01.CON.0000511068.61017.55","article-title":"The role of electrodiagnostic testing, imaging, and muscle biopsy in the investigation of muscle disease","volume":"22","author":"Rosow LK","year":"2016","unstructured":"Rosow LK Amato AA. The role of electrodiagnostic testing, imaging, and muscle biopsy in the investigation of muscle disease. Continuum (Minneap Minn) 2016;22(6 Muscle and Neuromuscular Junction Disorders):1787\u20131802.","journal-title":"Continuum (Minneap Minn)"},{"issue":"13","key":"e_1_3_2_88_2","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1001\/jama.2012.12607","article-title":"Mexiletine for symptoms and signs of myotonia in nondystrophic myotonia: a randomized controlled trial","volume":"308","author":"Statland JM","year":"2012","unstructured":"Statland JM Bundy BN Wang Y Mexiletine for symptoms and signs of myotonia in nondystrophic myotonia: a randomized controlled trial. JAMA 2012;308(13):1357\u20131365. doi:10.1001\/jama.2012.12607.","journal-title":"JAMA"},{"issue":"4","key":"e_1_3_2_89_2","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s00228-012-1414-3","article-title":"Dramatic improvement of myotonia permanens with flecainide: a two-case report of a possible bench-to-bedside pharmacogenetics strategy","volume":"69","author":"Desaphy J-F","year":"2013","unstructured":"Desaphy J-F Modoni A Lomonaco M Camerino DC. Dramatic improvement of myotonia permanens with flecainide: a two-case report of a possible bench-to-bedside pharmacogenetics strategy. Eur J Clin Pharmacol 2013;69(4):1037\u20131039. doi:10.1007\/s00228-012-1414-3.","journal-title":"Eur J Clin Pharmacol"},{"issue":"15","key":"e_1_3_2_90_2","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1212\/WNL.0000000000002416","article-title":"Randomized, placebo-controlled trials of dichlorphenamide in periodic paralysis","volume":"86","author":"Sansone VA","year":"2016","unstructured":"Sansone VA Burge J McDermott MP Randomized, placebo-controlled trials of dichlorphenamide in periodic paralysis. Neurology 2016;86(15):1408\u201316. doi:10.1212\/WNL.0000000000002416.","journal-title":"Neurology"}],"container-title":["Continuum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00132979-201612000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T13:58:24Z","timestamp":1752155904000},"score":1,"resource":{"primary":{"URL":"https:\/\/continuum.aan.com\/doi\/10.1212\/CON.0000000000000414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":89,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["10.1212\/CON.0000000000000414"],"URL":"https:\/\/doi.org\/10.1212\/con.0000000000000414","relation":{},"ISSN":["1080-2371","1538-6899"],"issn-type":[{"value":"1080-2371","type":"print"},{"value":"1538-6899","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12]]}}}